Hernia Mesh Lawsuit Information
Compensation, Eligibility & Claim Update

Have Questions?

---

FILL OUT THE FORM BELOW
TO REQUEST YOUR CASE REVIEW

Select Your State... Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District Of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

REVIEW MY CASE

By submitting I consent to be contacted to discuss my legal options by Lawsuit Legal and/or our legal partners and agree to receive calls, sms, emails. We may rely on co-counsel. I agree to the Terms of Use and Privacy Policy.

Latest Surgical Mesh Settlement & Lawsuit Updates

Are you suffering from complications due to a defective hernia mesh implant?

You're not alone. Roughly 26,000 hernia mesh cases remained pending across the federal dockets in early 2026, most of them moving through the Bard settlement program.

At Lawsuit Legal, our product liability attorneys review hernia mesh claims from patients nationwide.

We are continuing to investigate claims from injured parties who suffered hernia mesh complications.

If you had post-surgical complications, share what happened with our attorneys to learn if you are eligible to file for compensation.

July 2026: Where the Hernia Mesh Litigation Stands

The Bard MDL (MDL 2846, Southern District of Ohio) still listed 23,695 pending actions on the JPML's March 2026 report, most of them working through settlement administration rather than heading to trial. New Bard claims continue to be filed. The Atrium C-QUR litigation (MDL 2753, District of New Hampshire) has been resolved through a confidential settlement, with a court-approved qualified settlement fund paying eligible claimants.

February 2026: First Covidien Bellwether Trial Date Vacated

The first bellwether trial in the Covidien Parietex litigation (MDL 3029, District of Massachusetts) had been set for February 2026 before the court vacated the date. Roughly 2,300 Covidien cases remain pending, and pretrial work continues toward a new trial setting. Covidien is now the active litigation track for hernia mesh claims.

October 2024: Bard Settlement Framework Announced

Becton Dickinson, the parent company of C.R. Bard and Davol, announced a settlement framework reported to exceed $1 billion, covering more than 38,000 hernia mesh claims. Compensation is allocated through a points-based system tied to injury severity, and payments are processed in order of filing date.

November 2023: Third Bellwether Verdict for the Plaintiff

In Stinson v. C.R. Bard, the third bellwether trial in MDL 2846, the jury awarded the plaintiff $500,000 on negligence and failure-to-warn claims involving the PerFix Plug. The first bellwether had ended in a defense verdict and the second, Milanesi v. C.R. Bard, in a $255,000 plaintiff verdict.

Fill out the form to check your compensation eligibility. Filing deadlines depend on your state's statute of limitations.

 

Hernia Mesh Complications & Failure

Our hernia mesh attorneys are reviewing patient complication claims. Complications patients have named in lawsuits include the following adverse fact patterns.

• Adhesion: The mesh implant sticks to surrounding tissue and organs.
• Bowel Obstruction: The hernia mesh sticks to the intestines or moves around in the body, blocking the bowel.
• Delayed or Long-Term Complications: Chronic pain, migrations and hernia recurrence, remaining unfixed after failed original surgery.
• Groin or Testicular Pain: Pinched nerves after hernia mesh surgery resulting in a burning sensation surrounding the surgery site.
• Hernia Recurrence: Recurring hernia symptoms return after the mesh fails. Requiring revision surgery and further treatment.
• Infection: Potential for infection related complications around the surgical location and chronic inflammation.
• Migration: When the surgical mesh moves from the initial implant location to other organs and locations in the body.
• Pain & Suffering: Patients have reported claims of chronic pain persisting months and years after hernia mesh surgery, which can lead to permanent nerve damage.
• Perforation of Organs or Tissues: When the hernia mesh punctures organs or body tissue during migration.
• Revision Surgery: Depending on the extent of complications, multiple surgeries may be required to treat and remove the hernia mesh.
• Seromas: Patient claims of fluid pockets developing around the surgery site.

 

Erosion, organ perforation and other severe injuries commonly require revision surgeries and result in significant pain and suffering.

Estimates are that surgical mesh was employed in over 100,000 cases in 2010 alone, with 75 percent of these cases involving vaginal implantation.

Removing implanted mesh can be difficult as tissue grows around the material in the abdominal wall after it has been placed, which can lead to treatment requiring multiple revision surgeries.

Surgical mesh was used to treat pelvic organ prolapse and stress urinary incontinence in the U.S. since 1996. Mesh, however, first became a focus of personal injury litigation in October 2008 and again in February 2009, when the U.S. Food and Drug Administration issued Public Health Notifications regarding the use of mesh products in the treatment of pelvic organ prolapse and stress urinary incontinence. Device manufacturers Atrium, C.R. Bard, Bard Davol, and Ethicon have been named with open and pending lawsuit cases.

Hernia Mesh Lawsuits Claim:

• Defective Product Design
• Defective Product Manufacturing
• Improper labeling & Failure to warn patients about the risk of failure
• Medical Malpractice committed by plaintiffs' doctors who implanted the faulty mesh

Patients suing the hernia mesh manufacturers may be entitled to significant compensation.

Hernia Mesh Multi-District Litigation

Individual hernia mesh lawsuits have been consolidated under a multi-district litigation to be tried in a single court. The process is similar to a class action lawsuit, but claimants have individual suits and are able to negotiate independent settlements. Joining the consolidated litigation against the manufacturers of these products may provide a path to compensation for injuries sustained as a result of defective mesh.

If you qualify, you can file an individual hernia mesh lawsuit to join the pending litigation. Review the details of your case to determine if you qualify today.

Get your hernia mesh injury claim reviewed by our attorneys before the statute of limitations is reached. Find out if you qualify to file while the remaining dockets stay open. The closest medical-device parallel is the Paragard IUD breakage litigation, with comparable patterns appearing across other current medical-device and drug MDLs our attorneys are handling.

Surgical Mesh Lawsuit: Your Next Step

If mesh was used in your treatment and you have experienced complications, speak with our surgical mesh lawyers about your options. The statute of limitations in your state limits how long you have to file, and the Bard settlement program pays earlier-filed claims first.

New claims are still being filed in 2026. A claimant coming forward today can still file a Bard or Davol claim in MDL 2846, where late-filed cases are addressed after the original settlement group, or a Covidien Parietex claim in MDL 3029, which remains in active litigation. New Atrium C-QUR claims are limited now that the settlement fund has been approved.

 

Surgical Mesh Manufacturers: Are They Liable?

All three bellwether trials in the Bard MDL have been decided, and the docket has moved into settlement.

Plaintiffs claim affected mesh products are defective after people suffered serious injuries when their mesh implants failed. Claims include improper product labeling which failed to warn patients and doctors about the risk of complications, defective manufacturing, defective product design, and malpractice claims against the implanting doctors. The first bellwether trial resulted in a defense win, the second in a $255,000 verdict for the plaintiff, and the third, Stinson v. C.R. Bard, in a $500,000 plaintiff verdict in November 2023.